$50.21
0.37 (+0.74%)
Smith & Nephew plc (ADR) (NYSE:SNN)
CAPS Rating:
The Company is a global business engaged in the development, manufacture and marketing of medical devices in the sectors of orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management.
RSS Headlines
Fool UK
Recs
Great growth stock as the ortho company has increased market share each year. They continue to pressure leading competitors Zimmer and Stryker and are poised to overtake Zimmer in 2010.
They have addressed their inventory concerns from 2006 and are continuing to implement full lean processes. The SAP conversion from previously outdated BPCS will only aid in the management of their inventories.